Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazemetostat in Recurrent/Refractory and/or Metastatic MPNST
NCT04917042Phase 2Active, not recruiting
- Sponsor
- University of Florida
- Start
- Aug 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tazemetostat in malignant peripheral nerve sheath tumor (MPNST), sponsored by University of Florida. Started Aug 2021; status: active, not recruiting.
02
Drugs
tazemetostat
03
Conditions
malignant peripheral nerve sheath tumor (MPNST)
Beyond the preview
Go deeper on NCT04917042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04917042.